In Vitro Evaluation of Amide-Linked Coumarin Scaffolds for the Inhibition of α-Synuclein and Tau Aggregation
ACS Omega 2025, XXXX, XXX, XXX-XXX, DOI: 10.1021/acsomega.5c02435
ApoE3 Christ church and tau interaction as a protective mechanism against Alzheimer’s disease
Alzheimer’s & Dementia (2025), 21 (7), e70396 DOI: 10.1002/alz.70396
Tau aggregation induces cell death in iPSC-derived neurons
Aging Brain (2025) 7, 100136 DOI: 10.1016/j.nbas.2025.100136
Soluble tau aggregates decrease the threshold for thalamic oscillations and increase the excitability of thalamic neurons
Neuropharmacology (2025) 273, 110455 DOI: 10.1016/j.neuropharm.2025.110455
Hydromethylthionine sustains truncated tau-dependent inflammation-lowering effects in mouse brain
FEBS J (2025). DOI: 10.1111/febs.70021
Distinct tau and alpha-synuclein molecular signatures in Alzheimer’s disease with and without Lewy bodies and Parkinson’s disease with dementia
Acta Neuropathol (2024) 147 (1), 14 DOI: 10.1007/s00401-023-02657-y
Probing the Interactions of LRP1 Ectodomain-Derived Peptides with Fibrillar Tau Protein and Its Impact on Cellular Internalization
Applied Sciences (2023) 13 (2), 853 DOI: 10.3390/app13020853
Biochemical analyses of tau and other neuronal markers in the submandibular gland and frontal cortex across stages of Alzheimer disease
Neurosci Lett (2023) 810, 137330 DOI: 10.1016/j.neulet.2023.137330
Molecular determinants of the crosstalk between endosomal microautophagy and chaperone-mediated autophagy
Cell Reports (2023) 42 (12), 113529 DOI: 10.1016/j.celrep.2023.113529
Single-domain antibody–based noninvasive in vivo imaging of α-synuclein or tau pathology
Science Advances (2023) 9 (19), eadf3775 DOI: 10.1126/sciadv.adf3775